Peer Review History
| Original SubmissionSeptember 18, 2020 |
|---|
|
PONE-D-20-29479 Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research PLOS ONE Dear Dr. Wagenaar, Thank you very much for submitting your manuscript "Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research" (PONE-D-20-29479) for consideration at PLOS ONE. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. Please submit your revised manuscript by Dec 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Abdallah M. Samy, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This article entitled Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research presents a statistical model adapted from standard epidemiological models. Its objective is to show us that existing models should be viewed with caution given the lack of knowledge on the viral characteristics of SARS-CoV-2. The authors therefore offer us a new model, necessarily based on assumptions (not the same as the previous models) and vary certain parameters of interest to explain to you at the end that various variations on distinct parameters can lead to a fairly high prediction. This is the very principle of probabilities and statistics: an accumulation of errors can nevertheless lead to a fair result. And because of this, it is very difficult to say that one model is more or less fair than another, simply because the data and parameters are often inherent in the structure that creates the model. In the case of this article there is nothing new about varying parameters and checking the impact they have on the dynamics of SARS-CoV-2. It is very judicious to want to take into account the movements of population according to time but where are the elementary parameters accounting for the functioning of the virus, for example it is completely false to suppose that the contagiousness of an individual of a class of age is strictly that of another individual of the same age group at time t. The contagion of each individual very probably evolves according to his viral load and the viral load is not constant over time. This article entitled Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research presents a statistical model adapted from standard epidemiological models. Its objective is to show us that existing models should be viewed with caution given the lack of knowledge on the viral characteristics of SARS-CoV-2. The authors therefore offer us a new model, necessarily based on assumptions (not the same as the previous models) and vary certain parameters of interest to explain to you at the end that various variations on distinct parameters can lead to a fairly high prediction. fair. This is the very principle of probabilities and statistics: an accumulation of errors can nevertheless lead to a fair result. And because of this, it is very difficult to afford to say that one model is more or less fair than another, simply because the data and parameters are often inherent in the structure that creates the model. In the case of this article one thing is for sure, there is nothing new about varying parameters and checking the impact they have on the dynamics of SARS-CoV-2. It is very judicious to want to take into account the movements of population according to time but where are the elementary parameters accounting for the functioning of the virus, for example it is completely false to suppose that the contagiousness of an individual of a class of age is strictly that of another individual of the same age group at time t. The contagion of each individual very probably evolves according to his viral load and the viral load is not constant over time. Likewise, to make the model more complex, it would be wise to take into account an infection reduction coefficient which is due to the implementation of health measures (for example homeworking). Finally, it seems to me very difficult conceptually to vary certain parameters but to fix others while explaining to us that it is very dangerous to set parameters to evaluate the dynamics of a virus. From this perspective, it would have been undoubtedly much more interesting and coherent to try to present a nonparametric model of evolution of the dynamics of SARS-CoV-2. Reviewer #2: In the present paper titled “Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research”, the authors addressed the validity of various assumptions using an epidemiological simulation model. Result feedback that multiple scenarios all lead to realistic numbers of deaths and ICU admissions, two observable and verifiable metrics, but gave different estimates for the number of infected and immune individuals. To validate the assumption on the spread of virus or disease, the present paper applied a popular classical model called the SEIR model and agent-based simulation which can address the challenges in the SEIR model. The study was timing and output were interesting and shows its originality. The paper was well structured, the method and materials for assumption and the corresponding results, technical support is sound enough. However, the authors may wish to consider minor revisions as follows to the manuscript: • The reader may benefit from a definition of the SEIR model and agent-based simulation with short theory. • In the abstract review, more considerable information should be given to represent the whole contributions of the present manuscript. • If possible it is suggested to add legend on figures. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research PONE-D-20-29479R1 Dear Dr. Wagenaar, We’re pleased to inform you that your manuscript, "Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research" (PONE-D-20-29479R1), has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abdallah M. Samy, PhD Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-20-29479R1 Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research Dear Dr. Wagenaar: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abdallah M. Samy Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .